Sortis



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Hypercholesterolaemia 27.7%
Hypertension 12.7%
Hyperlipidaemia 9.4%
Blood Cholesterol Increased 6.9%
Type Iia Hyperlipidaemia 5.3%
Dyslipidaemia 4.3%
Coronary Artery Disease 4.1%
Myocardial Infarction 3.8%
Essential Hypertension 3.6%
Angina Pectoris 3.1%
Prophylaxis 2.8%
Type 2 Diabetes Mellitus 2.8%
Alpha-1 Anti-trypsin Deficiency 2.5%
Myocardial Ischaemia 2.5%
Coronary Heart Disease 1.8%
Acute Myocardial Infarction 1.5%
Blood Triglycerides Increased 1.5%
Pneumonia Bacterial 1.5%
Dementia Alzheimer's Type 1.0%
Diabetes Mellitus 1.0%
Myalgia 12.3%
Rhabdomyolysis 7.7%
Muscle Atrophy 6.9%
Transaminases Increased 6.9%
Polyneuropathy 6.2%
Muscle Spasms 5.4%
Weight Decreased 5.4%
Liver Injury 4.6%
Tendonitis 4.6%
Blood Creatine Phosphokinase Increased 3.8%
Death 3.8%
Hepatocellular Injury 3.8%
Neuropathy Peripheral 3.8%
Pain In Extremity 3.8%
Skin Exfoliation 3.8%
Tendon Rupture 3.8%
Type 2 Diabetes Mellitus 3.8%
Gamma-glutamyltransferase Increased 3.1%
Muscle Disorder 3.1%
Myocardial Infarction 3.1%
Secondary
Drug Use For Unknown Indication 20.3%
Hypercholesterolaemia 12.0%
Hyperlipidaemia 11.2%
Hypertension 11.2%
Product Used For Unknown Indication 7.0%
Essential Hypertension 6.5%
Myocardial Infarction 3.9%
Angina Pectoris 3.1%
Coronary Artery Disease 3.1%
Blood Cholesterol Increased 2.9%
Coronary Heart Disease 2.6%
Dyslipidaemia 2.1%
Renal Impairment 2.1%
Agitation 1.8%
Depression 1.8%
Diabetes Mellitus 1.8%
Prophylaxis 1.8%
Dementia Alzheimer's Type 1.6%
Renal Disorder 1.6%
Schizophrenia 1.6%
Rash 13.8%
Rhabdomyolysis 11.5%
Muscle Atrophy 9.2%
Gamma-glutamyltransferase Increased 5.7%
Muscular Weakness 5.7%
Myalgia 5.7%
Drug Exposure During Pregnancy 4.6%
International Normalised Ratio Increased 4.6%
Myocardial Infarction 4.6%
Haemolysis 3.4%
Liver Injury 3.4%
Mixed Liver Injury 3.4%
Nephrotic Syndrome 3.4%
Neuropathy Peripheral 3.4%
Schizophrenia 3.4%
Sleep Apnoea Syndrome 3.4%
Tendonitis 3.4%
Blood Triglycerides Increased 2.3%
Convulsion 2.3%
Dermatitis Allergic 2.3%
Concomitant
Product Used For Unknown Indication 26.9%
Hypertension 14.5%
Drug Use For Unknown Indication 13.4%
Rheumatoid Arthritis 5.0%
Pain 4.6%
Coronary Artery Disease 3.9%
Diabetes Mellitus 3.5%
Hyperlipidaemia 3.3%
Type 2 Diabetes Mellitus 3.3%
Osteoporosis 2.8%
Prophylaxis 2.8%
Hypercholesterolaemia 2.6%
Depression 2.0%
Atrial Fibrillation 1.9%
Essential Hypertension 1.7%
Renal Transplant 1.7%
Asthma 1.6%
Acute Myocardial Infarction 1.5%
Constipation 1.4%
Multiple Myeloma 1.4%
Vomiting 9.8%
Renal Failure Chronic 8.4%
Syncope 6.3%
Hypertension 5.6%
Hyponatraemia 5.6%
Progressive Multifocal Leukoencephalopathy 5.6%
Pyrexia 5.6%
Renal Failure Acute 5.6%
Hypotension 4.9%
Pancreatitis 4.9%
Myocardial Infarction 4.2%
Nausea 4.2%
Renal Failure 4.2%
Weight Decreased 4.2%
Femur Fracture 3.5%
General Physical Health Deterioration 3.5%
Gynaecomastia 3.5%
Neutropenia 3.5%
Restlessness 3.5%
Toxic Epidermal Necrolysis 3.5%
Interacting
Drug Use For Unknown Indication 16.4%
Hypertension 14.5%
Myocardial Infarction 14.5%
Depression 10.9%
Hyperlipidaemia 5.5%
Atrial Fibrillation 3.6%
Bacterial Infection 3.6%
Essential Hypertension 3.6%
Hypercholesterolaemia 3.6%
Hypoglycaemia 3.6%
Type 2 Diabetes Mellitus 3.6%
Acute Myocardial Infarction 1.8%
Alopecia 1.8%
Analgesic Therapy 1.8%
Atrial Flutter 1.8%
Blood Cholesterol Increased 1.8%
Breast Cancer 1.8%
Candidiasis 1.8%
Cardiac Disorder 1.8%
Cardiac Failure 1.8%
Hypersensitivity 10.0%
Liver Disorder 10.0%
Myalgia 10.0%
Transaminases Increased 10.0%
Hepatic Function Abnormal 5.0%
Hyperphosphataemia 5.0%
Hyponatraemia 5.0%
International Normalised Ratio Increased 5.0%
Low Density Lipoprotein Increased 5.0%
Lymphadenopathy 5.0%
Muscle Spasms 5.0%
Red Blood Cell Sedimentation Rate Increased 5.0%
Syncope 5.0%
Thrombocytopenia 5.0%
Tremor 5.0%
Type 2 Diabetes Mellitus 5.0%